133P Personalized circulating tumor DNA (ctDNA) during neoadjuvant therapy (NAT) to predict response in patients (pts) with early-stage breast cancer (eBC) Article Swipe
M. George
,
T. Meghal
,
Eshan U. Patel
,
Anya M. Litvak
,
S. Jacoby
,
Feng Yin
,
Surbhi Shah
,
S P Leitner
,
A.L. Cruz
,
Kathleen Toomey
,
Ekaterina Kalashnikova
,
Rebecca Watters
,
Coral Omene
,
Armando A. Rodriguez
,
Salma K. Jabbour
,
Shridar Ganesan
,
D. Toppmeyer
,
M.C. Liu
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/j.esmoop.2023.101472
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/j.esmoop.2023.101472
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.esmoop.2023.101472
- OA Status
- gold
- Cited By
- 2
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4376613698
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4376613698Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.esmoop.2023.101472Digital Object Identifier
- Title
-
133P Personalized circulating tumor DNA (ctDNA) during neoadjuvant therapy (NAT) to predict response in patients (pts) with early-stage breast cancer (eBC)Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-05-01Full publication date if available
- Authors
-
M. George, T. Meghal, Eshan U. Patel, Anya M. Litvak, S. Jacoby, Feng Yin, Surbhi Shah, S P Leitner, A.L. Cruz, Kathleen Toomey, Ekaterina Kalashnikova, Rebecca Watters, Coral Omene, Armando A. Rodriguez, Salma K. Jabbour, Shridar Ganesan, D. Toppmeyer, M.C. LiuList of authors in order
- Landing page
-
https://doi.org/10.1016/j.esmoop.2023.101472Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.esmoop.2023.101472Direct OA link when available
- Concepts
-
Nat, Circulating tumor DNA, Breast cancer, Medicine, Neoadjuvant therapy, Oncology, Internal medicine, Stage (stratigraphy), Cancer, Biology, Computer network, Paleontology, Computer scienceTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2023: 2Per-year citation counts (last 5 years)
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4376613698 |
|---|---|
| doi | https://doi.org/10.1016/j.esmoop.2023.101472 |
| ids.doi | https://doi.org/10.1016/j.esmoop.2023.101472 |
| ids.openalex | https://openalex.org/W4376613698 |
| fwci | 0.44517014 |
| type | article |
| title | 133P Personalized circulating tumor DNA (ctDNA) during neoadjuvant therapy (NAT) to predict response in patients (pts) with early-stage breast cancer (eBC) |
| biblio.issue | 1 |
| biblio.volume | 8 |
| biblio.last_page | 101472 |
| biblio.first_page | 101472 |
| topics[0].id | https://openalex.org/T11287 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1306 |
| topics[0].subfield.display_name | Cancer Research |
| topics[0].display_name | Cancer Genomics and Diagnostics |
| topics[1].id | https://openalex.org/T11369 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9807999730110168 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2734 |
| topics[1].subfield.display_name | Pathology and Forensic Medicine |
| topics[1].display_name | Genetic factors in colorectal cancer |
| topics[2].id | https://openalex.org/T10336 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9535999894142151 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Cancer Cells and Metastasis |
| is_xpac | False |
| apc_list.value | 2750 |
| apc_list.currency | EUR |
| apc_list.value_usd | 2965 |
| apc_paid.value | 2750 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 2965 |
| concepts[0].id | https://openalex.org/C182516595 |
| concepts[0].level | 2 |
| concepts[0].score | 0.8285281658172607 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q376660 |
| concepts[0].display_name | Nat |
| concepts[1].id | https://openalex.org/C2781335228 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7456952333450317 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q19596321 |
| concepts[1].display_name | Circulating tumor DNA |
| concepts[2].id | https://openalex.org/C530470458 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6593389511108398 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q128581 |
| concepts[2].display_name | Breast cancer |
| concepts[3].id | https://openalex.org/C71924100 |
| concepts[3].level | 0 |
| concepts[3].score | 0.6588542461395264 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[3].display_name | Medicine |
| concepts[4].id | https://openalex.org/C2778292576 |
| concepts[4].level | 4 |
| concepts[4].score | 0.6204569935798645 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q6991934 |
| concepts[4].display_name | Neoadjuvant therapy |
| concepts[5].id | https://openalex.org/C143998085 |
| concepts[5].level | 1 |
| concepts[5].score | 0.619143009185791 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[5].display_name | Oncology |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.5116896629333496 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C146357865 |
| concepts[7].level | 2 |
| concepts[7].score | 0.45890918374061584 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q1123245 |
| concepts[7].display_name | Stage (stratigraphy) |
| concepts[8].id | https://openalex.org/C121608353 |
| concepts[8].level | 2 |
| concepts[8].score | 0.41816478967666626 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[8].display_name | Cancer |
| concepts[9].id | https://openalex.org/C86803240 |
| concepts[9].level | 0 |
| concepts[9].score | 0.1118592917919159 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[9].display_name | Biology |
| concepts[10].id | https://openalex.org/C31258907 |
| concepts[10].level | 1 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q1301371 |
| concepts[10].display_name | Computer network |
| concepts[11].id | https://openalex.org/C151730666 |
| concepts[11].level | 1 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7205 |
| concepts[11].display_name | Paleontology |
| concepts[12].id | https://openalex.org/C41008148 |
| concepts[12].level | 0 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[12].display_name | Computer science |
| keywords[0].id | https://openalex.org/keywords/nat |
| keywords[0].score | 0.8285281658172607 |
| keywords[0].display_name | Nat |
| keywords[1].id | https://openalex.org/keywords/circulating-tumor-dna |
| keywords[1].score | 0.7456952333450317 |
| keywords[1].display_name | Circulating tumor DNA |
| keywords[2].id | https://openalex.org/keywords/breast-cancer |
| keywords[2].score | 0.6593389511108398 |
| keywords[2].display_name | Breast cancer |
| keywords[3].id | https://openalex.org/keywords/medicine |
| keywords[3].score | 0.6588542461395264 |
| keywords[3].display_name | Medicine |
| keywords[4].id | https://openalex.org/keywords/neoadjuvant-therapy |
| keywords[4].score | 0.6204569935798645 |
| keywords[4].display_name | Neoadjuvant therapy |
| keywords[5].id | https://openalex.org/keywords/oncology |
| keywords[5].score | 0.619143009185791 |
| keywords[5].display_name | Oncology |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.5116896629333496 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/stage |
| keywords[7].score | 0.45890918374061584 |
| keywords[7].display_name | Stage (stratigraphy) |
| keywords[8].id | https://openalex.org/keywords/cancer |
| keywords[8].score | 0.41816478967666626 |
| keywords[8].display_name | Cancer |
| keywords[9].id | https://openalex.org/keywords/biology |
| keywords[9].score | 0.1118592917919159 |
| keywords[9].display_name | Biology |
| language | en |
| locations[0].id | doi:10.1016/j.esmoop.2023.101472 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210217024 |
| locations[0].source.issn | 2059-7029 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2059-7029 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | ESMO Open |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | ESMO Open |
| locations[0].landing_page_url | https://doi.org/10.1016/j.esmoop.2023.101472 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5022367684 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8559-4738 |
| authorships[0].author.display_name | M. George |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | M. George |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5114025445 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | T. Meghal |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | T. Meghal |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5020176794 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-2174-5004 |
| authorships[2].author.display_name | Eshan U. Patel |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | E. Patel |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5062853695 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-8413-0106 |
| authorships[3].author.display_name | Anya M. Litvak |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | A. Litvak |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5112863052 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | S. Jacoby |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | S. Jacoby |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5009839979 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-5997-0448 |
| authorships[5].author.display_name | Feng Yin |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | F. Yin |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5043602955 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-8351-0265 |
| authorships[6].author.display_name | Surbhi Shah |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | S. Shah |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5109064088 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | S P Leitner |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | S. Leitner |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5109606272 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | A.L. Cruz |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | A.L. Cruz |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5064115439 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Kathleen Toomey |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | K. Toomey |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5056045630 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-1078-0656 |
| authorships[10].author.display_name | Ekaterina Kalashnikova |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | E. Kalashnikova |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5021192069 |
| authorships[11].author.orcid | https://orcid.org/0000-0001-7486-7510 |
| authorships[11].author.display_name | Rebecca Watters |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | R. Watters |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5008527277 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-7824-1478 |
| authorships[12].author.display_name | Coral Omene |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | C. Omene |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5003505116 |
| authorships[13].author.orcid | https://orcid.org/0000-0003-3136-5240 |
| authorships[13].author.display_name | Armando A. Rodriguez |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | A.A. Rodriguez |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5069565044 |
| authorships[14].author.orcid | https://orcid.org/0000-0001-8200-5371 |
| authorships[14].author.display_name | Salma K. Jabbour |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | S. Jabbour |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5061989008 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-5404-3044 |
| authorships[15].author.display_name | Shridar Ganesan |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | S. Ganesan |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5014296284 |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | D. Toppmeyer |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | D. Toppmeyer |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5015284180 |
| authorships[17].author.orcid | |
| authorships[17].author.display_name | M.C. Liu |
| authorships[17].author_position | last |
| authorships[17].raw_author_name | M.C. Liu |
| authorships[17].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.esmoop.2023.101472 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | 133P Personalized circulating tumor DNA (ctDNA) during neoadjuvant therapy (NAT) to predict response in patients (pts) with early-stage breast cancer (eBC) |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11287 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1306 |
| primary_topic.subfield.display_name | Cancer Research |
| primary_topic.display_name | Cancer Genomics and Diagnostics |
| related_works | https://openalex.org/W2263577673, https://openalex.org/W2338954311, https://openalex.org/W2926354809, https://openalex.org/W2224319365, https://openalex.org/W812572266, https://openalex.org/W2148796794, https://openalex.org/W2013223170, https://openalex.org/W3010405621, https://openalex.org/W4322772378, https://openalex.org/W4283030645 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2023 |
| counts_by_year[0].cited_by_count | 2 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1016/j.esmoop.2023.101472 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210217024 |
| best_oa_location.source.issn | 2059-7029 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2059-7029 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | ESMO Open |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | ESMO Open |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.esmoop.2023.101472 |
| primary_location.id | doi:10.1016/j.esmoop.2023.101472 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210217024 |
| primary_location.source.issn | 2059-7029 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2059-7029 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | ESMO Open |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | ESMO Open |
| primary_location.landing_page_url | https://doi.org/10.1016/j.esmoop.2023.101472 |
| publication_date | 2023-05-01 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 96 |
| cited_by_percentile_year.min | 94 |
| countries_distinct_count | 0 |
| institutions_distinct_count | 18 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7200000286102295 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.73798619 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |